Chinese Pharmaceuticals & Biotech Undervalued Dividend Payers

Yunnan Baiyao GroupLtd

Market Cap: CN¥86.3b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥39.4b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Beijing Tongrentang

Market Cap: CN¥31.7b

Engages in the production and sale of traditional Chinese medicine preparations in China and internationally.

Dong-E-E-Jiao

Market Cap: CN¥29.9b

Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.

Livzon Pharmaceutical Group

Market Cap: CN¥24.1b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

Tasly Pharmaceutical Group

Market Cap: CN¥21.0b

Engages in the research, development, production, and sale of pharmaceuticals in China.

Zhejiang Jiuzhou Pharmaceutical

Market Cap: CN¥12.3b

Operates as contract development and manufacturing organization (CDMO) company in China and internationally.

Tianjin Ringpu Bio-TechnologyLtd

Market Cap: CN¥7.0b

Engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products.

Amoy Diagnostics

Market Cap: CN¥6.5b

Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.